These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17062068)
41. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? Zivkovich AH; Feldman SR J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382 [TBL] [Abstract][Full Text] [Related]
42. Use of hyaluronan dressings following dermabrasion avoids escharectomy and facilitates healing in pediatric burn patients. Esposito G; Gravante G; Filingeri V; Delogu D; Montone A Plast Reconstr Surg; 2007 Jun; 119(7):2346-2347. PubMed ID: 17519773 [No Abstract] [Full Text] [Related]
43. Galenics of dermal products--vehicles, properties and drug release. Daniels R; Knie U J Dtsch Dermatol Ges; 2007 May; 5(5):367-83. PubMed ID: 17451381 [TBL] [Abstract][Full Text] [Related]
44. Enhancement of bioavailability by lowering of fat content in topical formulations. Wirén K; Frithiof H; Sjöqvist C; Lodén M Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336 [TBL] [Abstract][Full Text] [Related]
45. [From aqua jogging to skiing. Advisable sports for patients with arthrosis]. MMW Fortschr Med; 2003 Dec; 145(49):59. PubMed ID: 14964001 [No Abstract] [Full Text] [Related]
46. Vehicle effect on topical drug delivery. II. Concurrent skin transport of drugs and vehicle components. Møllgaard B; Hoelgaard A Acta Pharm Suec; 1983; 20(6):443-50. PubMed ID: 6675423 [No Abstract] [Full Text] [Related]
47. Novel topical drug delivery systems and their potential use in acne vulgaris. Taglietti M; Hawkins CN; Rao J Skin Therapy Lett; 2008 Jun; 13(5):6-8. PubMed ID: 18648713 [TBL] [Abstract][Full Text] [Related]
48. Submucosal fluid cushion and EMR: who rules the roost? Farrell JJ Gastrointest Endosc; 2008 May; 67(6):840-2. PubMed ID: 18440376 [No Abstract] [Full Text] [Related]
49. Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption. Nguyen V; Cunningham BB; Eichenfield LF; Alió AB; Buka RL J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S123-5. PubMed ID: 17938025 [No Abstract] [Full Text] [Related]
50. Instability of topical ciclosporin emulsion for nail psoriasis. Prins AM; Vos K; Franssen EJ Dermatology; 2007; 215(4):362-3. PubMed ID: 17911999 [No Abstract] [Full Text] [Related]
51. New trends in face rejuvenation by hyaluronic acid injections. Andre P J Cosmet Dermatol; 2008 Dec; 7(4):251-8. PubMed ID: 19146600 [TBL] [Abstract][Full Text] [Related]
52. Skin rejuvenation without a scalpel. I. Fillers. Haneke E J Cosmet Dermatol; 2006 Jun; 5(2):157-67. PubMed ID: 17173591 [TBL] [Abstract][Full Text] [Related]
53. [Special features of topical and systemic dermatologic therapy in children]. Lukas A; Wolf G; Fölster-Holst R J Dtsch Dermatol Ges; 2006 Aug; 4(8):658-78; quiz 679-80. PubMed ID: 16895569 [No Abstract] [Full Text] [Related]
54. [Clinical observations on the use of hyaluronic acid in dermatologic therapy]. Venturini D G Ital Dermatol Venereol; 1985; 120(1):V-X. PubMed ID: 4007930 [No Abstract] [Full Text] [Related]
55. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245 [TBL] [Abstract][Full Text] [Related]
56. [Therapy using dermatologic agents]. Pflugshaupt C Ther Umsch; 1989 Feb; 46(2):89-93. PubMed ID: 2928984 [TBL] [Abstract][Full Text] [Related]
57. Absorption, distribution, metabolism and excretion of hyaluronic acid during pregnancy: a matter of molecular weight. Unfer V; Tilotta M; Kaya C; Noventa M; Török P; Alkatout I; Gitas G; Bilotta G; Laganà AS Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):823-840. PubMed ID: 33999749 [TBL] [Abstract][Full Text] [Related]
58. [Importance of local skin treatments during radiotherapy for prevention and treatment of radio-induced epithelitis]. Chargari C; Fromantin I; Kirova YM Cancer Radiother; 2009 Jul; 13(4):259-66. PubMed ID: 19524470 [TBL] [Abstract][Full Text] [Related]
59. Hyaluronate and risperidone for hemorrhagic cystitis. Focosi D; Kast RE Bone Marrow Transplant; 2007 Jan; 39(1):57. PubMed ID: 17115061 [No Abstract] [Full Text] [Related]
60. [Interactions between active substance and base in dermatological topical therapy]. Gloor M Hautarzt; 1992 Feb; 43(2):105-10. PubMed ID: 1548128 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]